fda2f0db05f67c6215cfe25083d9af57:bf8b4a477528a35f6384f0571dcdfbd42d5cd7d671ac9402344b4a91295484d4de6468b5711d54f9cbcf9ca4500ca1a926a912edc540790e9aba079f3a70b2a79f81d6dc77a93effca01d5cbef598216a3dcc94f3355dd0d4a79157b7d835a33751d292d26db4854d5c843651e5f5b4d395753923a7c8a6065bfe90318e017384050b7027adc2a921ba631503bd2a6004ebb86a1219f66fd7ea13a3b18b9283808b2640f4cb24f2cae06ebaf4c784680a9db7aeead5a696b4f091df2932232f29a9bdf2dadadad607849db54d610dfcf57746edfe9995f2821f93f4cf8afd6afa4145df3be05f5b2356f151b9fa5aeac0765abf8228ae86808c357a666702d9c5e550a8b1be081fccf4bf02a6018780c8d0c9b0ed24c1d8f5247202876d403713aaa19710d3cf1ec260ad3e56a5cd2b7d452b6fc867f62f1eaf1cbbb660360ead172aea589fa98201ef7901b03dd3aeb1619b6e3699ce9aceb94ef56f22f61741e83e430b1b3ae538046edf4245c5629adc58e67a04d36b9ac54a7e4a0f0b53f2cb5a4db4beeff7bcf6769c9094e58e6036402a555e415a13ca75e94